psychedelics
08/27/2018 / By Isabelle Z.
Clinical trial using magic mushrooms to treat depression gets go-ahead from FDA
The FDA has just granted U.S. approval to a life sciences startup in London to use the psychedelic ingredient found in magic mushrooms in a trial for treating depression. The startup, Compass Pathways, was launched just two years ago with the backing of Peter Thiel. The trial is a phase IIB study of various dosages […]
1 of 1

Popular Articles

Nutraceuticals.News is a fact-based public education website published by Nutraceuticals News Features, LLC.

All content copyright © 2018 by Nutraceuticals News Features, LLC.

Contact Us with Tips or Corrections

All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

Privacy Policy